TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Cycurion ( (CYCU) ) just unveiled an announcement.
On December 2, 2025, Cycurion, Inc. announced it has been awarded a position on the State of Florida’s Management Consulting Services State Term Contract. This contract allows Cycurion to provide management consulting services to state agencies across Florida, supporting operational excellence and modernization. The award reflects Cycurion’s trusted track record and dedication to partnering with government customers, offering strategic planning, program management, and other advisory services to enhance public sector operations.
The most recent analyst rating on (CYCU) stock is a Hold with a $6.00 price target. To see the full list of analyst forecasts on Cycurion stock, see the CYCU Stock Forecast page.
Spark’s Take on CYCU Stock
According to Spark, TipRanks’ AI Analyst, CYCU is a Neutral.
Cycurion’s stock score is primarily impacted by its financial performance and technical analysis. The company shows some operational improvements, but high leverage and cash flow issues are significant concerns. Technical indicators suggest bearish momentum, and the negative P/E ratio further weighs down the valuation score.
To see Spark’s full report on CYCU stock, click here.
More about Cycurion
Based in McLean, Virginia, Cycurion, Inc. is a forward-thinking provider of IT cybersecurity solutions and AI, specializing in cybersecurity, program management, and business continuity. The company serves government, healthcare, and corporate clients worldwide, leveraging its AI-enhanced ARx platform and expert team to deliver secure and innovative services.
Average Trading Volume: 1,802,987
Technical Sentiment Signal: Sell
Current Market Cap: $10.83M
For an in-depth examination of CYCU stock, go to TipRanks’ Overview page.

